Gradual Egg-tolerance Induction in Hen's Egg Allergic Children Who Tolerate Baked Egg (TETI-II Study)
TETI-II
1 other identifier
interventional
62
1 country
4
Brief Summary
The investigators want to test the hypothesis that a total period of 12 months of stepwise open egg introduction is not inferior when compared to a total period of 20 months gradual open egg introduction of a certain egg product with regard to full egg tolerance induction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2020
CompletedFirst Submitted
Initial submission to the registry
December 15, 2020
CompletedFirst Posted
Study publicly available on registry
December 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedMarch 11, 2026
March 1, 2026
4.6 years
December 15, 2020
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Time to complete egg tolerance
The proportion of children in each group evolving from step 1 to step 5 within the anticipated time period (12 versus 20 months), followed by 3 versus 5 months of uneventful liberal egg intake for observation after step 5.
12 to 20 months
Secondary Outcomes (6)
The proportion of children evolving from any step to the next step within anticipated time period
3 to 5 months
Influence of age at inclusion in relation to the proportion of failures
12 to 20 months
Influence of specific IgE of hen's egg and/or components in relation to the proportion of failures
12 to 20 months
Influence of the dietary intake of the specific egg-containing products in relation to the proportion of failures
12 to 20 months
Induction of Treg over time in parallel to gradual complete hen's egg tolerance induction.
12 to 20 months
- +1 more secondary outcomes
Study Arms (2)
"Very short arm" (12 months)
ACTIVE COMPARATORVery short arm (12 months): 3 months between every step. Step by step gradual introduction of egg containing food products during 12 months, unless next step can not be taken.
"Short arm" (20 months)
ACTIVE COMPARATORShort arm (20 months): 5 months between every step. Step by step gradual introduction of egg containing food products during 20 months, unless next step can not be taken.
Interventions
Step by step gradual introduction of egg containing food products
Eligibility Criteria
You may qualify if:
- Children (1-18y) had or have a clinical diagnosis of IgE mediated hen's egg allergy based on positive history as well as skin prick testing and/or specific IgE detection by CAPtest in an allergy clinic
- Children are at least 12 months old before introduction of heated egg is considered
- Children did not suffer from grade 4 anaphylaxis due to egg-ingestion at presentation (for grade 4 anaphylaxis, see EAACI anaphylaxis guidelines, Muraro A et al, Allergy. 2014 Aug;69(8):1008-25).
- Children have specific IgE levels to Gal d 1 below 1.2 kU/mL (12-24 months) or below 5 kU/mL (\>24 months) or have a level that predicts a good chance (\>75%) to pass the baked egg provocation test by cake (see Bartnikas LM et al, J Allergy Clin Immunol Pract 2013; 1: 354-360) and/or children passed baked egg provocation test by cake executed on clinical judgement.
You may not qualify if:
- Children had grade 4 anaphylaxis (for grade 4 anaphylaxis, see EAACI anaphylaxis guidelines, Muraro A et al, Allergy. 2014 Aug;69(8):1008-25) due to egg ingestion
- Children are younger than 12 months old at the moment of passing cake open provocation test
- Parents are not able or not willing to adhere to a certain egg step-containing diet on a regular basis at home
- Parents and/or children are not willing to give IC/assent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AZ Sint-Jan AVcollaborator
- Dominque Bullenslead
- Imelda Hospital, Bonheidencollaborator
Study Sites (4)
University Hospital of Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Imelda Hospital Bonheiden
Bonheiden, Belgium
Sint-Jan
Bruges, Belgium
AZ maria middelares
Ghent, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominique Bullens, MD, PhD
Universitaire Ziekenhuizen KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 15, 2020
First Posted
December 21, 2020
Study Start
December 9, 2020
Primary Completion
July 2, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Data will be analysed and grouped before release